Secondary Progressive Multiple Sclerosis (SPMS)
Neurology·MeSH: Multiple Sclerosis
Prevalence
120.0 / 100K
Incidence
7.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Secondary Progressive Multiple Sclerosis (SPMS)?
There are 1 clinical trial targeting Secondary Progressive Multiple Sclerosis (SPMS) tracked by BioSniper.
What is the prevalence of Secondary Progressive Multiple Sclerosis (SPMS)?
The estimated prevalence of Secondary Progressive Multiple Sclerosis (SPMS) is approximately 120.0 per 100,000 population.
Deep-dive into Secondary Progressive Multiple Sclerosis (SPMS)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis